動物用診断の世界市場規模、シェア、成長分析、製品別、動物別、技術別 - 産業予測2023～2030年

世界の動物用診断の市場規模は、2022年に73億米ドルとなり、2023年の81億米ドルから、2031年までには190億米ドルに成長し、予測期間中（2024～2031年）のCAGRは11.2％で成長する見通しです。

世界の動物用診断市場は、動物疾病の蔓延と、それに伴う正確でタイムリーな診断ツールへの需要の高まりにより、近年大幅な成長を遂げています。特に新興国ではペットの飼育数が急増し、動物用診断市場の拡大に大きく寄与しています。さらに、獣医学分野では予防ヘルスケアへの関心が高まっており、病気の早期発見を目的とした診断検査への需要が高まっています。コンパニオンアニマル・ヘルスケアにおける顕著な急増は、動物の健康を確保するために診断サービスに投資するペットの飼い主の意欲の高まりです。地域的には、北米と欧州が獣医学的診断の顕著な市場であり、ペットヘルスケアに対する高い意識と確立された獣医学的インフラの恩恵を受けています。しかし、アジア太平洋とラテンアメリカの新興国が有望な成長機会をもたらしています。これらの地域における可処分所得の増加と動物の健康に対する意識の高まりが、動物用診断市場の成長を後押ししています。その結果、この分野で事業を展開する企業は、これらの急成長市場を活用するため、アジア太平洋とラテンアメリカでのプレゼンス拡大にますます注力しています。全体として、世界の動物用診断市場は、ペットの飼育、予防ヘルスケア、地理的範囲の拡大といった動向の進展に後押しされ、成長軌道を継続すると予想されます。

目次

エグゼクティブサマリー

• 市場概要
• 運命の輪

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模の推定
• 市場の前提条件と制限

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主な市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主な投資の分析
• 主な成功要因
• 競合の程度

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

動物用診断の世界市場：製品別

• 市場概要
• 免疫診断検査
• 分子診断検査
• 臨床化学
• 血液分析装置
• 画像診断

動物用診断の世界市場：動物別

• 市場概要
• 家畜
• コンパニオンアニマル

動物用診断の世界市場：技術別

• 市場概要
• PCR（ポリメラーゼ連鎖反応）
• ELISA（酵素結合免疫吸着測定法）
• マイクロアレイ
• 免疫測定法
• 画像診断技術（X線）
• MRI
• 超音波
• その他

動物用診断の世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2021年）
• 主な市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2021年）

主要企業プロファイル

• IDEXX Laboratories, Inc.
• Zoetis, Inc.
• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Virbac Corporation
• Heska Corporation
• Abaxis, Inc.
• NEOGEN Corporation
• Randox Laboratories Ltd.
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthcare
• Danaher Corporation
• Johnson & Johnson
• Pfizer
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health

Global Veterinary Diagnostics Market size was valued at USD 7.3 billion in 2022 and is poised to grow from USD 8.1 billion in 2023 to USD 19.0 billion by 2031, growing at a CAGR of 11.2% during the forecast period (2024-2031).

The global Veterinary Diagnostics market has observed a substantial growth recently, driven by the increasing prevalence of animal diseases and the consequent demand for accurate and timely diagnostic tools. Developed countries, in particular, have seen a surge in pet ownership, contributing significantly to the expansion of the veterinary diagnostics market. Furthermore, there is a growing attention on preventive healthcare in the veterinary field, leading to a rising demand for diagnostic tests aimed at early disease detection. A notable surge in companion animal healthcare is the growing willingness of pet owners to invest in diagnostic services to ensure the well-being of their animals. Geographically, North America and Europe have been prominent markets for veterinary diagnostics, benefiting from a high level of awareness about pet healthcare and well-established veterinary infrastructure. However, emerging economies in Asia-Pacific and Latin America are now presenting promising growth opportunities. Rising disposable incomes and increasing awareness of animal health in these regions are driving the growth of the veterinary diagnostics market. As a result, companies operating in this sector are increasingly focusing on expanding their presence in Asia-Pacific and Latin America to capitalize on these burgeoning markets. Overall, the global veterinary diagnostics market is expected to continue its growth trajectory, propelled by evolving trends in pet ownership, preventive healthcare, and expanding geographical reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Diagnostics Market Segmental Analysis

The global veterinary diagnostics market is segmented on the basis of product, animal, technology, and region. By product type, the market is segmented into immunodiagnostic tests, molecular diagnostic tests, clinical chemistry, hematology analyzers, and diagnostic imaging. By animal type, the market is segmented into livestock, companion animals. By technology, the market is segmented into, PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), microarrays, immunoassay, diagnostic imaging technologies (X-ray, MRI, Ultrasound), and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Global Veterinary Diagnostics Market

The increase in widespread presence of animal diseases emphasizes the need for precise and timely diagnostic tools to ensure prompt treatment and effective disease management. Furthermore, the rise in pet ownership, mainly in developed regions, is a significant driver of market growth because pet owners are increasingly seeking advanced healthcare solutions for their animal companions. Technological advancements in diagnostic tools, including molecular diagnostic tests and advanced imaging techniques, are playing an important role in maintaining the accuracy and efficiency of veterinary diagnostics. These innovations contribute to improved disease detection and treatment outcomes, thus benefiting both animals and their owners.

Restraints in the Global Veterinary Diagnostics Market

The main problem for the veterinary diagnostics market is the high cost of advanced methods and equipment. Buying and running these tools is expensive, especially for clinics and labs in places with little money. Also, there's a challenge because rules about these tools are different in each country. These different rules can make it hard to bring new diagnostic technologies into some places.

Market Trends of the Global Veterinary Diagnostics Market

There's a trend in veterinary diagnostics where high-tech stuff like artificial intelligence and machine learning are getting used more. These technologies help make diagnosing diseases in animals faster and more accurate. Another trend is that vets are using point-of-care diagnostics, where they can do tests right where the animal is being treated. This makes it faster to make decisions and start treatment. Also, telemedicine in veterinary care is becoming more common, where vets can do consultations remotely using digital platforms and share diagnostic information online.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Veterinary Diagnostics Market by Product

• Market Overview
• Immunodiagnostic Tests
• Molecular Diagnostic Tests
• Clinical Chemistry
• Hematology Analyzers
• Diagnostic Imaging

Global Veterinary Diagnostics Market by Animal

• Market Overview
• Livestock
• Companion Animals

Global Veterinary Diagnostics Market by Technology

• Market Overview
• PCR (Polymerase Chain Reaction)
• ELISA (Enzyme-Linked Immunosorbent Assay)
• Microarrays
• Immunoassay
• Diagnostic Imaging Technologies (X-ray
• MRI
• Ultrasound)
• and Others

Global Veterinary Diagnostics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abaxis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments